Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 241

1.

Against vaccine assay secrecy.

Herder M, Hatchette TF, Halperin SA, Langley JM.

Hum Vaccin Immunother. 2015 Feb;11(2):498-503. doi: 10.4161/21645515.2014.980194.

PMID:
25826194
2.

A universal infant rotavirus vaccine program in two delivery models: Effectiveness and adverse events following immunization.

Sanford C, Langley JM, Halperin SA, Zelman M, Mvrvp.

Hum Vaccin Immunother. 2015 Apr 3;11(4):870-4. doi: 10.1080/21645515.2015.1012028.

PMID:
25746110
3.

Maintaining the momentum: key factors influencing acceptance of influenza vaccination among pregnant women following the H1N1 pandemic.

Halperin BA, MacKinnon-Cameron D, McNeil S, Kalil J, Halperin SA.

Hum Vaccin Immunother. 2014;10(12):3629-41. doi: 10.4161/21645515.2014.980684.

PMID:
25668670
4.

Outcomes of invasive meningococcal disease in adults and children in Canada between 2002 and 2011: a prospective cohort study.

Sadarangani M, Scheifele DW, Halperin SA, Vaudry W, Le Saux N, Tsang R, Bettinger JA; investigators of the Canadian Immunization Monitoring Program, ACTive (IMPACT); investigators of the Canadian Immunization Monitoring Program ACTive IMPACT.

Clin Infect Dis. 2015 Apr 15;60(8):e27-35. doi: 10.1093/cid/civ028. Epub 2015 Jan 20.

PMID:
25605282
5.

Immunogenicity of heterologous H5N1 influenza booster vaccination 6 or 18 months after primary vaccination in adults: a randomized controlled clinical trial.

Langley JM, Frenette L, Jeanfreau R, Halperin SA, Kyle M, Chu L, McNeil S, Dramé M, Moris P, Fries L, Vaughn DW.

Vaccine. 2015 Jan 15;33(4):559-67. doi: 10.1016/j.vaccine.2014.11.018. Epub 2014 Nov 21.

6.
7.

Low pertussis toxin antibody levels in two regional cohorts of Canadian pregnant women.

Bigham M, Konrad S, Van Buynder P, Van Buynder J, Isaac-Renton J, ElSherif M, Halperin SA.

Vaccine. 2014 Nov 12;32(48):6493-8. doi: 10.1016/j.vaccine.2014.09.028. Epub 2014 Sep 27.

PMID:
25269092
8.

Acellular vaccines for preventing whooping cough in children.

Zhang L, Prietsch SO, Axelsson I, Halperin SA.

Cochrane Database Syst Rev. 2014 Sep 17;9:CD001478. doi: 10.1002/14651858.CD001478.pub6. Review.

PMID:
25228233
9.

Implementation of a universal rotavirus vaccination program: comparison of two delivery systems.

Zelman M, Sanford C, Neatby A, Halperin BA, MacDougall D, Rowswell C, Langley JM, Halperin SA; Maritime Universal Rotavirus Vaccination Program (MURVP).

BMC Public Health. 2014 Sep 2;14:908. doi: 10.1186/1471-2458-14-908.

10.

The impact of the meningococcal serogroup C conjugate vaccine in Canada between 2002 and 2012.

Sadarangani M, Scheifele DW, Halperin SA, Vaudry W, Le Saux N, Tsang R, Bettinger JA; investigators of the Canadian Immunization Monitoring Program, ACTive (IMPACT).

Clin Infect Dis. 2014 Nov;59(9):1208-15. doi: 10.1093/cid/ciu597. Epub 2014 Jul 28.

PMID:
25069868
11.

CD43-, but not CD43+, IL-10-producing CD1dhiCD5+ B cells suppress type 1 immune responses during Chlamydia muridarum genital tract infection.

Moore-Connors JM, Kim HS, Marshall JS, Stadnyk AW, Halperin SA, Wang J.

Mucosal Immunol. 2015 Jan;8(1):94-106. doi: 10.1038/mi.2014.45. Epub 2014 Jun 18.

PMID:
24938746
12.

Burden of seasonal influenza in children with neurodevelopmental conditions.

Burton C, Vaudry W, Moore D, Bettinger JA, Tran D, Halperin SA, Scheifele DW; IMPACT investigators.

Pediatr Infect Dis J. 2014 Jul;33(7):710-4. doi: 10.1097/INF.0000000000000272.

PMID:
24918745
13.

Knowledge, attitudes, beliefs and behaviours of older adults about pneumococcal immunization, a Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) investigation.

Schneeberg A, Bettinger JA, McNeil S, Ward BJ, Dionne M, Cooper C, Coleman B, Loeb M, Rubinstein E, McElhaney J, Scheifele DW, Halperin SA.

BMC Public Health. 2014 May 12;14:442. doi: 10.1186/1471-2458-14-442.

14.

Childhood immunization rates in Canada are too low: UNICEF.

Scheifele DW, Halperin SA, Bettinger JA.

Paediatr Child Health. 2014 May;19(5):237-8. No abstract available.

15.

Nonhuman primate and human challenge models of pertussis.

Merkel TJ, Halperin SA.

J Infect Dis. 2014 Apr 1;209 Suppl 1:S20-3. doi: 10.1093/infdis/jit493. Review.

16.

Comparison of the Safety and Immunogenicity of a Novel Quadrivalent Meningococcal ACWY-Tetanus Toxoid Conjugate Vaccine and a Marketed Quadrivalent Meningococcal ACWY-Diphtheria Toxoid Conjugate Vaccine in Healthy Individuals 10-25 Years of Age.

Halperin SA, Baine Y, Domachowske JB, Aggarwal N, Simon M, Langley JM, McNeil SA, Friedland LR, Bianco V, Baccarini CI, Miller JM.

J Pediatric Infect Dis Soc. 2014 Mar;3(1):33-42. Epub 2013 Oct 17.

17.

Influenza immunization practices and policies for health care students in Canada.

Pianosi K, Chobotuk T, Halperin BA, Halperin SA.

Can J Infect Dis Med Microbiol. 2013 Winter;24(4):195-201.

18.

Approved but non-funded vaccines: accessing individual protection.

Scheifele DW, Ward BJ, Halperin SA, McNeil SA, Crowcroft NS, Bjornson G.

Vaccine. 2014 Feb 7;32(7):766-70. doi: 10.1016/j.vaccine.2013.12.027. Epub 2013 Dec 25. Review.

19.

Safety and immunogenicity of a toddler dose following an infant series of a hexavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b, hepatitis B vaccine administered concurrently or at separate visits with a heptavalent pneumococcal conjugate vaccine.

Halperin SA, Tapiéro B, Dionne M, Meekison W, Diaz-Mitoma F, Zickler P, Rubin E, Embree J, Bhuyan P, Lee A, Li M, Tomovici A.

Pediatr Infect Dis J. 2014 Jan;33(1):73-80. doi: 10.1097/01.inf.0000437806.76221.20.

PMID:
24346596
20.

Applicability of the Brighton Collaboration Case Definition for seizure after immunization in active and passive surveillance in Canada.

Top KA, Constantinescu CM, Laflèche J, Bettinger JA, Scheifele DW, Vaudry W, Halperin SA, Law BJ.

Vaccine. 2013 Nov 19;31(48):5700-5. doi: 10.1016/j.vaccine.2013.09.048. Epub 2013 Oct 5.

PMID:
24099871
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk